Prenetics, a Nasdaq-listed healthcare company backed by David Beckham, has made a bold move into Bitcoin.
The genomics and diagnostics firm announced it has invested $20 million to purchase 187.42 BTC, making it the first publicly traded healthcare company to add Bitcoin to its balance sheet.
Prenetics described the investment as part of its broader strategy to enhance shareholder value and diversify its treasury holdings.
Prenetics Backs Bitcoin as Long-Term Value Store Amid Rising Institutional Support
The company cited growing institutional acceptance of Bitcoin and its potential as a long-term store of value.
This move signals a rare crossover between the healthcare and crypto sectors, highlighting the increasing appeal of digital assets beyond traditional tech and finance industries.
The purchase was made at an average price of around $106,722 per BTC.
Prenetics Integrates Bitcoin as Core Treasury Strategy, Not Just a Test
Prenetics is integrating Bitcoin into their primary financial plan rather than merely experimenting with it.
The company demonstrated a strong belief in the long-term potential of the digital asset when it announced plans to commit the majority of its balance sheet to Bitcoin.
Prenetics has previously obtained board permission for the allocation, demonstrating a purposeful and strategic change, thus this is not a hasty decision.
The company wants to use Bitcoin’s potential as a store of value and an inflation hedge rather than letting cash lie around doing nothing.
In addition to joining the increasing number of businesses that are using cryptocurrency as a treasury asset, Prenetics is the first healthcare organization to do so on this scale, indicating a significant convergence of financial decentralization and medical innovation.
Also Read: Cross-Border Care Made Simple, Bitcoin Eliminates Currency Barriers In Medical Tourism: Report
Prenetics Joins Emerging Trend of Healthcare Firms Embracing Bitcoin
Prenetics’ bold move into Bitcoin comes amid a growing trend of healthcare firms exploring digital assets as part of their financial strategies.
While Prenetics is the first publicly traded healthcare company to formally disclose a significant Bitcoin investment, it isn’t entirely alone in exploring digital assets.
In May 2024, Semler Scientific, a Nasdaq-listed medical technology firm specializing in cardiovascular diagnostics, announced it had purchased 871 BTC as part of its strategy to adopt Bitcoin as a treasury reserve asset.
As macroeconomic uncertainty, inflation, and fiat currency devaluation persist, companies across sectors are rethinking how they manage cash reserves—and healthcare is no exception.
While traditionally conservative, several healthcare and biotech firms are beginning to view Bitcoin not just as a speculative asset but as a potential hedge and store of value.
These firms are also recognizing Bitcoin’s rising institutional legitimacy, increasing liquidity, and appeal as a non-correlated asset class.
In Prenetics’ case, its sizable $20 million investment and decision to allocate a majority of its balance sheet to BTC reflect growing confidence in crypto’s long-term utility.
This shift signals that the healthcare sector, once distant from the crypto conversation, is now paying attention—diversifying not just treatments and technologies, but also financial models in a rapidly evolving economic landscape.
Also Read: Swedish Health Company H100 Group Share Soar by 45% Following $10M Funding For Bitcoin Investment